← Open Payments lookup

FAISAL TAI: Open Payments

NPI 1619381316 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$598 in 22 payments from 11 companies in 2025. Trend: 2023 $8,753 · 2024 $23,897 · 2025 $598

Food & beverage: $598
CompanyPaymentsAmount
Janssen Scientific Affairs, LLC1$129
Janssen Pharmaceuticals, Inc4$106
ABBVIE INC.5$105
Otsuka America Pharmaceutical, Inc.3$58
Neurocrine BioSciences, Inc.2$48
Alkermes, Inc.2$40
Axsome Therapeutics, Inc.1$26
Luye Pharma (USA) Ltd.1$24
E.R. Squibb & Sons, L.L.C.1$22
Corium, LLC1$21

Products named: SPRAVATO, VRAYLAR, REXULTI, INGREZZA, ARISTADA, Auvelity, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.